A detailed history of Cookson Peirce & CO Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Cookson Peirce & CO Inc holds 3,036 shares of NVO stock, worth $311,584. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,036
Previous 3,070 1.11%
Holding current value
$311,584
Previous $438,000 17.58%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $4,048 - $4,944
-34 Reduced 1.11%
3,036 $361,000
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $12,271 - $14,691
-100 Reduced 3.15%
3,070 $438,000
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $144,139 - $316,270
1,585 Added 100.0%
3,170 $288,000
Q2 2023

Aug 01, 2023

BUY
$155.98 - $172.65 $247,228 - $273,650
1,585 New
1,585 $257,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cookson Peirce & CO Inc Portfolio

Follow Cookson Peirce & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cookson Peirce & CO Inc with notifications on news.